Acute, recurrent fosfomycin-induced liver toxicity in an adult patient with cystic fibrosis.
We report a very unusual adverse effect--fosfomycin-induced repeat liver toxicity--in a female adult with cystic fibrosis (CF).
Durupt
S
S
Cystic Fibrosis Center, Department of Internal Medicine, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
Josserand
R N
RN
Sibille
M
M
Durieu
I
I
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D003550:Cystic Fibrosis / Q000150:complications*; D005260:Female; D005578:Fosfomycin / Q000009:adverse effects*; D006529:Hepatomegaly / Q000139:chemically induced / Q000473:pathology; D006801:Humans; D008099:Liver / Q000473:pathology*; D008107:Liver Diseases / Q000473:pathology; D012008:Recurrence
D000900:Anti-Bacterial Agents; D005578:Fosfomycin